Results 1 to 10 of about 75,701 (257)
Cardiac resynchronization therapy in ischemic and non‐ischemic cardiomyopathy
Journal of Arrhythmia, 2017 Cardiac resynchronization therapy (CRT) using a biventricular pacing system has been an effective therapeutic strategy in patients with symptomatic heart failure with a reduced left ventricular ejection fraction (LVEF) of 35% or less and a QRS duration ...
Hisashi Yokoshiki
exaly +5 more sources
Advancements in nanomedicine for modulating ischemic cardiomyopathy therapy [PDF]
Materials Today BioIschemic cardiomyopathy receives significant attention due to its high mortality and morbidity worldwide. Numerous research has revealed that blood supply, ROS, inflammation, and thrombus play pivotal roles in the progression of myocardial damage and ...
Xiangyi Ren +5 more
doaj +2 more sources
Ischemic and non-ischemic dilated cardiomyopathy
Open Medicine, 2014 Abstract Dilated Cardiomyopathy is a high-incident disease, which diagnosis of and treatments are clinical priority. The aim of our study was to evaluate the diagnostic potential of cardiac magnetic resonance (CMR) imaging; echocardiography and the biochemical parameters that can help us differentiate between the post-ischemic and non ...
Fazio Giovanni +5 more
doaj +4 more sources
Frontiers in Cardiovascular Medicine, 2022 BackgroundMechanisms of sex-based differences in outcomes following cardiac resynchronization therapy (CRT) are poorly understood.ObjectiveTo use cardiac magnetic resonance (CMR) to define mechanisms of sex-based differences in outcomes after CRT and ...
Derek J. Bivona +16 more
doaj +1 more source
BMC Cardiovascular Disorders, 2021 Background Psoriasis is a chronic inflammatory skin condition commonly associated with psoriatic arthritis, malignancy, diabetes, inflammatory bowel disease, and cardiovascular disease.
Abbas Alshami +6 more
doaj +1 more source
Frontiers in Cell and Developmental Biology, 2022 Background: Ferroptosis is a new form of cell death recently discovered that is distinct from apoptosis, necrosis and autophagy. This article is expected to provide a new direction for the treatment of cardiomyopathy in the future by screening potential ...
Yufeng Jiang +4 more
doaj +1 more source
Social Inequalities in Non-ischemic Cardiomyopathies
Frontiers in Cardiovascular Medicine, 2022 Heart failure (HF) has various characteristics, such as etiology, clinical course, and clinical characteristics. Several studies reported the clinical findings of the characteristics of non-ischemic cardiomyopathy.
Eisuke Amiya, Eisuke Amiya
doaj +1 more source
Revascularization of chronic total occlusion coronary artery and cardiac regeneration
Frontiers in Cardiovascular Medicine, 2022 Coronary chronic total occlusion (CTO) contributes to the progression of heart failure in patients with ischemic cardiomyopathy. Randomized controlled trials demonstrated that percutaneous coronary intervention (PCI) for CTO significantly improves angina
Ruoxi Liao +4 more
doaj +1 more source
Journal of Arrhythmia, 2021 Background The implantable cardiac defibrillator is the cornerstone of prevention of sudden cardiac death in non‐ischemic cardiomyopathy. The Selvester score, which is frequently investigated in ischemic cardiomyopathy, has not been investigated in the ...
Fazıl Arısoy +5 more
doaj +1 more source
American Heart Journal Plus, 2023 Background: The optimal revascularization approach in patients with heart failure with reduced ejection fraction (HFrEF) and ischemic heart disease (“ischemic cardiomyopathy”) is unknown.
Amrita Mukhopadhyay +6 more
doaj +1 more source